bispitcanada

Holistic Management: Integrating Lifestyle, Supplements, and Monitoring

Holistic Management: Integrating Lifestyle, Supplements, and Monitoring The Comorbidity ChallengeGout rarely exists in isolation; 65% of patients have hypertension, 40% diabetes, and 30% CKD. The 2019 EULAR guidelines emphasize a “treat-to-target” approach combining urate-lowering therapy (ULT) with comorbidity management.BISPIT’s Ecosystem Approach

Holistic Management: Integrating Lifestyle, Supplements, and Monitoring Read More »

Innovations in Crystal Dissolution: From Surgery to Oral Therapeutics

Innovations in Crystal Dissolution: From Surgery to Oral Therapeutics The Limitations of Traditional TherapiesSurgical tophi excision, while effective, carries risks of infection and recurrence. Pharmacological options like pegloticase (a PEGylated uricase) are costly and require biweekly infusions, limiting accessibility. BISPIT’s Oral Crystal DissolutionGOUT RELIEF 3310 B+ employs a multi-target strategy: Nanjing University Clinical TrialA 2025 double-blind

Innovations in Crystal Dissolution: From Surgery to Oral Therapeutics Read More »

Scroll to Top